The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-noradamantyl-1,3-dipropylxanthine ID: ALA385372
Max Phase: Preclinical
Molecular Formula: C20H28N4O2
Molecular Weight: 356.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCn1c(=O)c2nc(C34CC5CC(C3)C(C5)C4)[nH]c2n(CCC)c1=O
Standard InChI: InChI=1S/C20H28N4O2/c1-3-5-23-16-15(17(25)24(6-4-2)19(23)26)21-18(22-16)20-9-12-7-13(10-20)14(8-12)11-20/h12-14H,3-11H2,1-2H3,(H,21,22)
Standard InChI Key: IDHJABAMUQNMKF-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
3.8440 -17.2469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4774 -17.9305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0146 -18.0585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1689 -18.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6634 -18.7831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3039 -19.3692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8475 -18.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5361 -17.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0852 -19.3213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3033 -20.1925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6312 -20.6761 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7148 -21.4629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8902 -21.4602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4826 -22.1705 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8885 -22.8863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7173 -22.8848 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1277 -22.1717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4810 -23.6043 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9506 -22.1686 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6555 -22.1744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2443 -21.4602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4193 -21.4599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1290 -23.6029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9519 -23.6027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3631 -22.8844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9700 -20.6784 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4 6 1 0
5 6 1 0
7 8 1 0
3 7 1 0
2 8 1 0
6 9 1 0
9 8 1 0
1 2 1 0
1 3 1 0
2 4 1 0
10 11 1 0
11 13 1 0
6 10 1 0
12 13 2 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
15 18 2 0
17 19 2 0
14 20 1 0
20 21 1 0
21 22 1 0
16 23 1 0
23 24 1 0
24 25 1 0
3 5 1 0
12 26 1 0
26 10 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 356.47Molecular Weight (Monoisotopic): 356.2212AlogP: 2.78#Rotatable Bonds: 5Polar Surface Area: 72.68Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.42CX Basic pKa: 2.46CX LogP: 3.23CX LogD: 3.20Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.90Np Likeness Score: -0.43
References 1. Kiesman WF, Zhao J, Conlon PR, Dowling JE, Petter RC, Lutterodt F, Jin X, Smits G, Fure M, Jayaraj A, Kim J, Sullivan G, Linden J.. (2006) Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists., 49 (24): [PMID:17125264 ] [10.1021/jm0605381 ]